Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Urology|May 2, 2017
Indocyanine Green Angiography-assisted Laparoendoscopic Single-site VaricocelectomyKeiji Tomita, Susumu Kageyama, Eiki Hanada, et al.
IJU Case Reports|August 4, 2020
Syndrome of inappropriate antidiuretic hormone secretion as a side effect of chemotherapy for testicular cancer: A case reportKoki Maeda, Susumu Kageyama, Takashi Osafune, et al.
Oncology Letters|January 16, 2023
Prognostic nutritional index of early post-pembrolizumab therapy predicts long-term survival in patients with advanced urothelial carcinomaSusumu Kageyama, Tetsuya Yoshida, Kenichi Kobayashi, et al.
BMC Urology|June 1, 2018
The location of the bladder neck in postoperative cystography predicts continence convalescence after radical prostatectomySusumu Kageyama, Tetsuya Yoshida, Masayuki Nagasawa, et al.
Oncology Letters|January 25, 2019
Changes in renal function following nedaplatin-containing chemotherapy in patients with urothelial carcinoma unfit for cisplatinMasayuki Nagasawa, Susumu Kageyama, Tetsuya Yoshida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 7, 2017
Urological laparoendoscopic single-site and reduced port surgery: A nationwide survey in JapanMitsuhiro Narita, Susumu Kageyama, Takatsugu Okegawa, et al.
Plos One|September 28, 2018
Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimensRyosuke Murai, Yasushi Itoh, Susumu Kageyama, et al.
The Prostate|August 21, 2021
Clinical, pathological, and therapeutic features of newly diagnosed prostate cancer predominantly detected by opportunistic PSA screening: A survey of Shiga Prefecture, JapanYuki Okinaka, Susumu Kageyama, Koji Nishizawa, et al.
Cancers|June 22, 2023
Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI TrialKazuhiro Kitajima, Junpei Kuyama, Takashi Kawahara, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2022
Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) TrialKazuhiro Kitajima, Masataka Igeta, Junpei Kuyama, et al.
Pageof 5